Tandlægeselskabet Godt Smil Roskilde ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  0.5% 0.5% 0.5% 0.5% 0.5%  
Bankruptcy risk  3.8% 3.1% 5.0% 5.5% 5.8%  
Credit score (0-100)  51 55 43 40 40  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  14,857 13,859 13,164 14,756 13,749  
EBITDA  3,691 2,417 3,440 4,484 3,868  
EBIT  3,177 1,890 2,912 4,106 3,642  
Pre-tax profit (PTP)  3,158.7 1,874.7 2,881.1 4,070.6 3,631.3  
Net earnings  2,458.3 1,461.0 2,245.6 3,172.5 2,825.7  
Pre-tax profit without non-rec. items  3,159 1,875 2,881 4,071 3,631  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  1,573 1,528 1,056 861 818  
Shareholders equity total  2,133 1,594 2,090 1,812 1,638  
Interest-bearing liabilities  301 214 124 31.3 0.0  
Balance sheet total (assets)  5,643 5,033 4,074 4,137 3,404  

Net Debt  -2,337 -2,062 -1,623 -2,237 -1,453  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  14,857 13,859 13,164 14,756 13,749  
Gross profit growth  14.6% -6.7% -5.0% 12.1% -6.8%  
Employees  17 18 14 15 14  
Employee growth %  13.3% 5.9% -22.2% 7.1% -6.7%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  5,643 5,033 4,074 4,137 3,404  
Balance sheet change%  6.6% -10.8% -19.1% 1.5% -17.7%  
Added value  3,690.6 2,417.2 3,440.3 4,634.6 3,867.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -889 -572 -1,001 -574 -268  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  5.0 5.0 5.0 5.0 5.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  21.4% 13.6% 22.1% 27.8% 26.5%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  58.4% 35.7% 64.3% 100.7% 97.1%  
ROI %  102.7% 69.6% 124.3% 196.3% 201.3%  
ROE %  107.9% 78.4% 121.9% 162.6% 163.8%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  40.3% 33.6% 54.2% 44.8% 48.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -63.3% -85.3% -47.2% -49.9% -37.6%  
Gearing %  14.1% 13.4% 5.9% 1.7% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  19.2% 12.7% 28.0% 79.9% 199.1%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  1.4 1.2 2.1 1.7 1.9  
Current Ratio  1.5 1.2 2.1 1.8 2.1  
Cash and cash equivalent  2,637.9 2,275.6 1,747.0 2,267.8 1,452.8  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  1,248.6 620.2 1,494.9 1,363.3 1,281.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  217 134 246 309 276  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  217 134 246 299 276  
EBIT / employee  187 105 208 274 260  
Net earnings / employee  145 81 160 212 202